MI

MIRA PHARMACEUTICAL INC.

Health & Medical Registered 25 October 2013
Follow

General Information

Official company information

Registry ID
2393389
Company Age
11 years
Registration Date
Business Number (BN)
833663438
City
MARKHAM
Status Notes
2022-10-26
Email
N/A
Website
mirapharmaceuticals.com/

Official company website with more information about products, services, and contact details.

About MIRA PHARMACEUTICAL INC.

Company profile and description

MIRA Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical development company. It operates as a clinical development stage biopharmaceutical company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline.

Category

Business category and classification details

Primary Category
Health & Medical
Description
Providers of medical, dental, therapeutic, and other health-related services, including hospitals, clinics, private practices, and pharmacies.

Additional Information

Detailed company information and status

Version
1778839506652233732
Hierarchy
parent
Entity Type
ONTARIO BUSINESS CORP.
Display Date
2013-10-25
Jurisdiction
ON
Status Notes
incorporated
Business Number
833663438
MRAS Entity Type
BCA

Company Contacts

Key contacts and leadership

Name & Position Email Contact Number Fax Number

Request For Information Free

We will attempt to gather this information through our sources

Current requests: 0

Similar Companies

Companies in the same industry or category

View All in Health & Medical

In the News

Recent media coverage and press mentions

No recent media coverage

No recent news articles found for MIRA PHARMACEUTICAL INC.

Social Media

Connect with MIRA PHARMACEUTICAL INC.